最近の論文

印刷

  • HOME
  • 最近の論文

最近の論文

2018年 | 2017年 | 2016年 | 2015年 | 2014年 | 2013年

Okamoto, K., Ohishi, T., Kuroiwa, M., Iemura, S., Natsume, T. and Seimiya, H.
MERIT40-dependent recruitment of tankyrase to damaged DNA and its implication for cell sensitivity to DNA-damaging anticancer drugs.
Oncotarget, 9, 35844-35855 (2018)
Yonekura, R., Osako, T., Iwase, T., Ogiya, A., Ueno, T., Kitagawa, M., Ohno, S. and Akiyama, F.
Prognostic impact and possible pathogenesis of lymph node metastasis in ductal carcinoma in situ of the breast.
Breast Cancer Res. Treat., in press (2018)
Hatta, T., Iemura, S., Ohishi, T., nakayama, H., Seimiya, H., Iizuka, K., Takeda, J., Natsume, T. and Horikawa, Y.
Calpain-10 regulates actin dynamics by proteolysis of microtubule-associated protein 1B.
Sci. Rep., 8, 16756 (2018)
Yamamoto, T., Sakamoto, C., Tachiwana, H., Kumabe, M., Matsui, T., Yamashita, T., Shinagawa, M., Ochiai, K., Saitoh, N. and Nakao, M.
Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA.
Sci. Rep., 8, 15202 (2018)
Fujiwara, C., Muramatsu, Y., Nishii, M., Tokunaka, K., Tahara, H., ueno, M., Yamori, T., Sugimoto, Y. and Seimiya, H.
Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells.
Sci. Rep., in press (2018)
Ma, Y., Tsushima, Y., Sakuma, M., Sasaki, S., Iida, K., Okabe, S., Seimiya, H., Hirokawa, T. and Nagasawa, K.
Development of G-quadruplex ligands for selective induction of a parallel-type topology.
Org. Biomol. Chem., in press (2018)
Mizutani, A., Yashiroda, Y., Muramatsu, Y., Yoshida, H., Chikada, T., Tsumura, T., Okue, M., Shirai, F., Fukami, T., Yoshida, M. and Seimiya, H.
RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model.
Cancer Sci., in press (2018)
Ichikawa, Y., Saitoh, N. and Kaufman, P. D.
An asymmetric centromeric nucleosome.
Elife, 7, e37911 (2018)
Kato, Y., Kunimasa, K., Sugimoto, Y. and Tomida, A.
BCR-ABL tyrosine kinase inhibition induces metabolic vulnerability by preventing the integrated stress response in K562 cells.
Biochem. Biophys. Res. Commun., in press (2018)
Ukaji, T., Takemoto, A., Katayama, R., Takeuchi, K. and Fujita, N.
A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis).
Oncotarget, 9, 33322-33336 (2018)

このページのTOPへ